{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:17:22Z","timestamp":1778624242947,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,9]],"date-time":"2027-04-09T00:00:00Z","timestamp":1807228800000},"content-version":"am","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA271331"],"award-info":[{"award-number":["R01CA271331"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA196521"],"award-info":[{"award-number":["P30 CA196521"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA260711"],"award-info":[{"award-number":["R01CA260711"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA271418"],"award-info":[{"award-number":["R01CA271418"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R00CA151827"],"award-info":[{"award-number":["R00CA151827"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F31HL142208"],"award-info":[{"award-number":["F31HL142208"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.exphem.2026.105403","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:28:08Z","timestamp":1772818088000},"page":"105403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Sustained MYC overexpression drives myeloid differentiation block and acquisition of leukemic phenotypes"],"prefix":"10.1016","volume":"157","author":[{"given":"Nicole","family":"Stokes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saul","family":"Carcamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deniz","family":"Demircioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuedi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malgorzata","family":"Olszewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7943-1636","authenticated-orcid":false,"given":"Dan","family":"Hasson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6017-6361","authenticated-orcid":false,"given":"Hideo","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirini P.","family":"Papapetrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9569-8402","authenticated-orcid":false,"given":"David","family":"Dominguez-Sola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2026.105403_bib0001","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.smim.2008.05.001","article-title":"How transcription factors program chromatin\u2014lessons from studies of the regulation of myeloid-specific genes","volume":"20","author":"Bonifer","year":"2008","journal-title":"Semin Immunol"},{"key":"10.1016\/j.exphem.2026.105403_bib0002","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2026.105403_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106733","article-title":"MYC overexpression is associated with an early disease progression from MDS to AML","volume":"111","author":"Gajzer","year":"2021","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2026.105403_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2019.106194","article-title":"Prognostic significance of MYC oncoprotein expression on survival outcome in patients with acute myeloid leukemia with myelodysplasia related changes (AML-MRC)","volume":"84","author":"Yun","year":"2019","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2026.105403_bib0005","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.molcel.2015.04.011","article-title":"Vakoc CR. BET bromodomain inhibition suppresses the function of hematopoietic transcription factors in acute myeloid leukemia","volume":"58","author":"Roe","year":"2015","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2026.105403_bib0006","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41573-025-01143-2","article-title":"MYC in cancer: from undruggable target to clinical trials","volume":"24","author":"Whitfield","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.exphem.2026.105403_bib0007","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/gcc.2870090111","article-title":"Localization of amplified MYC gene sequences to double minute chromosomes in acute myelogenous leukemia","volume":"9","author":"Slovak","year":"1994","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.exphem.2026.105403_bib0008","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cancergencyto.2009.04.003","article-title":"Acute myeloid leukemia with MYC amplification in the homogeneous staining regions and double minutes","volume":"192","author":"Lee","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.exphem.2026.105403_bib0009","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116427118","article-title":"Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes","volume":"118","author":"Ferraro","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2026.105403_bib0010","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/leu.2016.19","article-title":"Identification of MYC mutations in acute myeloid leukemias with NUP98-NSD1 translocations","volume":"30","author":"Lavallee","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2026.105403_bib0011","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2026.105403_bib0012","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nature25193","article-title":"A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies","volume":"553","author":"Bahr","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2026.105403_bib0013","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41588-018-0270-1","article-title":"Subtype-specific regulatory network rewiring in acute myeloid leukemia","volume":"51","author":"Assi","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2026.105403_bib0014","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.4161\/cc.8.8.8126","article-title":"Inhibition of cell differentiation: a critical mechanism for MYC-mediated carcinogenesis?","volume":"8","author":"Leon","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.exphem.2026.105403_bib0015","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/320760a0","article-title":"Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment","volume":"320","author":"Coppola","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2026.105403_bib0016","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0092-8674(86)90361-2","article-title":"The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice","volume":"47","author":"Langdon","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2026.105403_bib0017","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1101\/gad.313104","article-title":"c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation","volume":"18","author":"Wilson","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2026.105403_bib0018","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ceb.2009.09.006","article-title":"Myc's other life: stem cells and beyond","volume":"21","author":"Laurenti","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.exphem.2026.105403_bib0019","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1182\/blood-2005-02-0734","article-title":"Tomasson MH. c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations","volume":"106","author":"Luo","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2026.105403_bib0020","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood.2020006374","article-title":"MYC-induced human acute myeloid leukemia requires a continuing IL-3\/GM-CSF costimulus","volume":"136","author":"Bulaeva","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2026.105403_bib0021","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.stemcr.2018.03.020","article-title":"Dissecting the contributions of cooperating gene mutations to cancer phenotypes and drug responses with patient-derived iPSCs","volume":"10","author":"Chang","year":"2018","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.exphem.2026.105403_bib0022","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.stem.2017.01.009","article-title":"Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia","volume":"20","author":"Kotini","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2026.105403_bib0023","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41586-024-08137-x","article-title":"RAS-mutant leukaemia stem cells drive clinical resistance to venetoclax","volume":"636","author":"Sango","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2026.105403_bib0024","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.stem.2021.01.011","article-title":"Sequential CRISPR gene editing in human iPSCs charts the clonal evolution of myeloid leukemia and identifies early disease targets","volume":"28","author":"Wang","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2026.105403_bib0025","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2026.105403_bib0026","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/ng.3646","article-title":"Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution","volume":"48","author":"Corces","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2026.105403_bib0027","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/bioinformatics\/bty031","article-title":"Haystack: systematic analysis of the variation of epigenetic states and cell-type specific regulatory elements","volume":"34","author":"Pinello","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.exphem.2026.105403_bib0028","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1073\/pnas.94.2.569","article-title":"Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice","volume":"94","author":"Zhang","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2026.105403_bib0029","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrc1363","article-title":"EBPalpha mutations in acute myeloid leukaemias","volume":"4","author":"Nerlov","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2026.105403_bib0030","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/ni.3024","article-title":"The transcription repressors Bach2 and Bach1 promote B cell development by repressing the myeloid program","volume":"15","author":"Itoh-Nakadai","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.exphem.2026.105403_bib0031","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.celrep.2017.02.029","article-title":"A Bach2-Cebp gene regulatory network for the commitment of multipotent hematopoietic progenitors","volume":"18","author":"Itoh-Nakadai","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.exphem.2026.105403_bib0032","doi-asserted-by":"crossref","first-page":"17432","DOI":"10.1073\/pnas.1107303108","article-title":"Lymphomas that recur after MYC suppression continue to exhibit oncogene addiction","volume":"108","author":"Choi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2026.105403_bib0033","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1097-2765(00)80367-6","article-title":"Reversible tumorigenesis by MYC in hematopoietic lineages","volume":"4","author":"Felsher","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2026.105403_bib0034","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1126\/science.1071489","article-title":"Sustained loss of a neoplastic phenotype by brief inactivation of MYC","volume":"297","author":"Jain","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.exphem.2026.105403_bib0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10428194.2018.1464158","article-title":"MYC protein expression is an important prognostic factor in acute myeloid leukemia","volume":"60","author":"Ohanian","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2026.105403_bib0036","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X26000366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X26000366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T14:35:49Z","timestamp":1777041349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X26000366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":36,"alternative-id":["S0301472X26000366"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2026.105403","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained MYC overexpression drives myeloid differentiation block and acquisition of leukemic phenotypes","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2026.105403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Experimental Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105403"}}